Clinical Trial Update: Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases [Phase 2]

View source ↗

Summary

A Pfizer-sponsored Phase 2 neoadjuvant trial for colorectal cancer with unresectable liver metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Cancer

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms, Liver Neoplasms | Phase 2 | Status: TERMINATED